Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery

Recruiting Phase 3 Interventional Study
Blood Pressure Management Intraoperative Hypotension Non-cardiac Surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
750 (estimated)
Sponsor
Jagiellonian University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOn-caRdiac surgery. The study aims to determine whether perioperative noradrenaline infusion is superior to standard blood pressure management for the occurrence of perioperative hypotension.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. ≥45 years old 2. Elective or accelerated\* non-cardiac surgery expected to last ≥1 hour and requiring general, neuraxial, or combined general with neuraxial anesthesia 3. Expected to stay overnight in the hospital after surgery 4. Written informed consent to participate in th…
Contacts

Bożena Seczyńska, PhD

(+48) 124332847

bozena.seczynska@uj.edu.pl

CONTACT

Zbigniew Putowski, MD, PhD

(+48) 126308267

zbigniew.putowski@uj.edu.pl

CONTACT